Allergan's Hope For Rival Deal Dims Amid Investor Outcry
Deal watchers expected Allergan Inc. to unveil a multibillion-dollar merger with Salix Pharmaceuticals Ltd. by Friday as part of its plan to fend off a hostile takeover, but amid stiff investor...To view the full article, register now.
Already a subscriber? Click here to view full article